RECRUITINGOBSERVATIONAL
Biobank for Inflammatory Chronic Diseases and Osteoporosis
Biobank for Inflammatory Chronic Diseases and Osteoporosis of TOULouse
About This Trial
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
Who May Be Eligible (Plain English)
Who May Qualify:
- Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
- With National Health Assurance
- Able to consent to the study
Who Should NOT Join This Trial:
- Pregnancy or breastfeeding
- Not able to give a consent
- Severe anemia (Hb\<10g/L)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
* With National Health Assurance
* Able to consent to the study
Exclusion Criteria:
* Pregnancy or breastfeeding
* Not able to give a consent
* Severe anemia (Hb\<10g/L)
Treatments Being Tested
BIOLOGICAL
Blood sampling
4 tubes of 7 mL will be sampled
Locations (1)
Purpan University Hospital
Toulouse, France